$117.83 -0.3 -0.2%
Last Trade - 22/01/21
| Market Cap | £2.79bn |
| Enterprise Value | £2.87bn |
| Revenue | £503.8m |
| Position in Universe | 1585th / 6630 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 541.4 | 552.5 | 553.2 | 594.8 | 643.7 | 643.7 | 699.3 | 737.1 | +3.5% | ||
| +17.5 | +10.9 | -5.8 | +14.3 | +18.9 | +4.5 | +30.5 | +2.36 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry, providing solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems and cereal systems. The Animal Nutrition & Health segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment sells ethylene oxide as a sterilant gas primarily for use in the healthcare industry. The Industrial Products segment includes the manufacture and sale of methylamines.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| Incorporated | January 30, 1967 |
| Public Since | June 3, 1986 |
| No. of Shareholders: | 73 |
| No. of Employees: | 1,424 |
| Sector | Consumer Defensives |
| Industry | Food & Tobacco |
| Index | Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 , |
| Exchange | NASDAQ Global Select Market |
| Shares in Issue | 32,351,112 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 52 Sunrise Park Rd, NEW HAMPTON, 10958-4703, United States |
| Web | http://www.balchem.com/ |
| Phone | +1 845 3265600 |
| Contact | () |
| Auditors | RSM US LLP |
As of 22/01/21, shares in Balchem are trading at $117.83, giving the company a market capitalisation of £2.79bn. This share price information is delayed by 15 minutes.
Shares in Balchem are currently trading at $117.83 and the price has moved by 9.21% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Balchem price has moved by -6.59% over the past year.
Of the analysts with advisory recommendations for Balchem, there are there are currently 1 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Balchem is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Balchem is scheduled to issue upcoming financial results on the following dates:
The Balchem dividend yield is 0.44% based on the trailing twelve month period.
Last year, Balchem paid a total dividend of 0.52, and it currently has a trailing dividend yield of 0.44%. Looking ahead, Balchem has not announced an ex-dividend date yet.
Balchem has yet to annouce their ex-dividend date. The historic dividend yield on Balchem shares is currently 0.44%.
To buy shares in Balchem you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Balchem are currently trading at $117.83, giving the company a market capitalisation of £2.79bn.
Here are the trading details for Balchem:
Based on an overall assessment of its quality, value and momentum, Balchem is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Balchem are currently priced at $117.83. At that level they are trading at 0.07% premium to the analyst consensus target price of 0.00.
Analysts covering Balchem currently have a consensus Earnings Per Share (EPS) forecast of 3.307 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Balchem. Over the past six months, the relative strength of its shares against the market has been 0.87%. At the current price of $117.83, shares in Balchem are trading at 16.91% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Balchem PE ratio based on its reported earnings over the past 12 months is 44.84. The shares are currently trading at $117.83.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Balchem's management team is headed by:
Here are the top five shareholders of Balchem based on the size of their shareholding:
